Application

17934119 · METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

Filed 2022-09-21 · Granted · Patent 11598767 (2023-03-07) The official file ↗The patent and its PDF ↗ · Art unit 1657 · Examiner Satyendra K Singh Typical · CPC A61M 5/168 · Horizon Therapeutics USA, Inc. · COOLEY LLP / Horizon Therapeutics PLC

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

3.4 mo

to disposition 5.5 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.